Thursday, February 5, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Reaffirms Positive Outlook on Phreesia PHR

Elaine Mendonca by Elaine Mendonca
March 15, 2024
in Breaking News
0
Finance_ Investing in stocks
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter

On March 15, 2024, analyst Ryan MacDonald from Needham reaffirmed his positive outlook on Phreesia (PHR) with a Buy rating and a price target of $29.

—

Phreesia (PHR) continues to receive strong support from analyst Ryan MacDonald at Needham, who believes in the company’s potential and has set a price target of $29.

PHR Stock Shows Positive Momentum on March 15, 2024: What Investors Need to Know

On March 15, 2024, PHR stock showed some positive momentum in its performance. The stock opened at $23.49, which was $0.82 higher than its previous close. Throughout the day, the price of PHR shares increased by $0.14, resulting in a 0.62% rise in value.

Despite this increase, PHR is currently trading in the middle of its 52-week range and below its 200-day simple moving average. This suggests that while there may be some short-term gains, the stock is not performing as strongly as it has in the past. Investors may want to consider the overall trend of PHR stock before making any decisions. Keeping an eye on the market trends and staying informed about the company’s financial health can help investors make more informed choices about their portfolio.

PHR Stock Performance Analysis: Revenue Up, Net Income Down – March 15, 2024

On March 15, 2024, PHR stock showed mixed performance based on the financial data provided by CNN Money. The company’s total revenue for the past year was $356.30 million, which represented a 26.84% increase compared to the previous year. However, the total revenue remained flat at $91.62 million in the third quarter.

Similarly, the net income for PHR was -$136.88 million for the past year, showing a 22.29% increase from the previous year. In the third quarter, the net income was -$31.94 million, which was the same as the previous quarter.

Earnings per share (EPS) for PHR was -$3.36 for the past year, indicating a 41.82% decrease compared to the previous year. In the third quarter, the EPS was -$0.58, showing a 15.42% increase from the previous quarter.

Overall, the financial performance of PHR stock on March 15, 2024, was a mix of positive and negative indicators. Investors may want to closely monitor the company’s financial performance and market trends to make informed decisions about investing in PHR stock.

Tags: PHR
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
DrugRetailers Stock Exchange

Analyst Reiterates Buy Rating on Dicks Sporting Goods Increases Price Target

Food Retailers Trading online

Loop Capital Analyst Reaffirms Hold Rating for Ulta Beauty with Increased Price Target

MMM stock news

The Power of Compounded Returns A Case Study of Union Pacific Stock

Recommended

SKYX Platforms Stock

Marriott Partnership Signals Major Breakthrough for SKYX Platforms

5 months ago
Microsoft Stock

Microsoft’s AI Ambition: A High-Stakes Bet on Future Growth

18 hours ago
Turtle Beach Stock

Turtle Beach Forges PlayStation Alliance with New Gaming Headset

5 months ago
FLO stock news

Cemtrex Shares Surge After Halting Trading Due to Circuit Breaker

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

CureVac Delisted Following BioNTech Acquisition Completion

Strategic Robotics Partnership Signals New Growth Phase for EOS Defence

NexPoint Residential Trust Sets Date for Annual and Q4 2025 Results

PC Connection Set to Report Full-Year and Fourth Quarter Earnings

Fossil Group Stock Surges Past Key Technical Threshold

NextGen Healthcare: Strategic Wins and Industry Accolades Signal Sustained Momentum

Trending

Rolls Royce Stock
Defense & Aerospace

Rolls-Royce Shares: A Pivotal Period for Growth and Diversification

by Dieter Jaworski
February 5, 2026
0

The coming weeks represent a critical juncture for Rolls-Royce. The company is poised to demonstrate whether it...

Viking Therapeutics Stock

Viking Therapeutics: Investors Await Key Clinical Updates in Forthcoming Report

February 5, 2026
Solana Stock

Solana Faces Billions in Potential Token Supply Releases

February 5, 2026
CureVac Stock

CureVac Delisted Following BioNTech Acquisition Completion

February 5, 2026
EOS Stock

Strategic Robotics Partnership Signals New Growth Phase for EOS Defence

February 5, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Rolls-Royce Shares: A Pivotal Period for Growth and Diversification
  • Viking Therapeutics: Investors Await Key Clinical Updates in Forthcoming Report
  • Solana Faces Billions in Potential Token Supply Releases

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com